Drug-labels.com Search Menu

Somatuline Autogel: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
60 mg, 90 mg, 120 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Somatuline Autogel

What is SOMATULINE® AUTOGEL® used for?

SOMATULINE® AUTOGEL® is recommended for:

  • The treatment of adults with acromegaly. Acromegaly is a condition where a gland in your brain produces too much growth hormone.
  • The treatment of adults with a type of cancer known as enteropancreatic neuroendocrine tumours. Enteropancreatic neuroendocrine tumours begin to grow in the stomach, intestines, appendix, or the pancreas. SOMATULINE® AUTOGEL® treats and controls the growth of tumours of the intestine and pancreas that:

    • cannot be removed by surgery or;
    • have spread
  • The treatment of adults with carcinoid syndrome. Carcinoid syndrome is a cancer condition that makes and releases certain chemicals into your blood. SOMATULINE® AUTOGEL® reduces the need for rescue drugs to treat carcinoid syndrome.

SOMATULINE® AUTOGEL® is not for use in children and adolescents under the age of 18.

How does SOMATULINE® AUTOGEL® work?

Lanreotide, the medicinal ingredient in SOMATULINE® AUTOGEL®, belongs to a group of medicines called antigrowth hormones. Lanreotide is similar to a hormone naturally made in your body called somatostatin. SOMATULINE® AUTOGEL® is believed to lower the levels of hormones in the body such as GH (growth hormone) and IGF-1 (insulin-like growth factor-1) and blocks the release of some hormones and secretions in the stomach and intestines.

Serious Warnings and Precautions

Treatment with SOMATULINE® AUTOGEL® may:

  • cause loss of blood sugar control if you have diabetes. Diabetes is a disease in which your blood sugar levels are too high.
  • cause gallstones in your gallbladder.
  • affect how well a drug called cyclosporine works. Cyclosporine is used to reduce the activity of the immune system. Taking SOMATULINE® AUTOGEL® may lower the levels of cyclosporine in your blood.

Additionally, it has an effect on some type of tumours of the intestine and pancreas by stopping or delaying their growth.

What are the ingredients in SOMATULINE® AUTOGEL®?

Medicinal ingredients: lanreotide (as lanreotide acetate).

Non-medicinal ingredients: glacial acetic acid and water for injection.

SOMATULINE® AUTOGEL® comes in the following dosage forms:

Solution for injection: 60 mg, 90 mg, 120 mg lanreotide (as lanreotide acetate).

Do not use SOMATULINE® AUTOGEL® if you:

  • are allergic to lanreotide or any of the other ingredients of SOMATULINE® AUTOGEL®.
  • are allergic to somatostatin or any other drug similar to somatostatin.
  • have untreated gallstones.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take SOMATULINE® AUTOGEL®. Talk about any health conditions or problems you may have, including if you:

  • are diabetic. Treatment may affect your blood sugar levels. Your healthcare professional may monitor your blood sugar levels after your first dose, when your dose is changed, and every so often during your treatment. They may also alter the drugs you use to treat your diabetes.
  • have or have had liver problems.
  • have or have had kidney problems.
  • have or have had heart problems. Treatment may slow your heart rate. Your healthcare professional may monitor your heart rate while on treatment.
  • have or have had gallbladder problems. Treatment may lead to the formation of gallstones in your gallbladder. Your healthcare professional may monitor your gallbladder when you take your first dose and while on treatment. Treatment may end should complications of gallstones occur.
  • have thyroid problems. Treatment may decrease your thyroid function if you are being treated for acromegaly.
  • are pregnant, planning to become pregnant. Avoid taking SOMATULINE® AUTOGEL® if you are pregnant and avoid becoming pregnant while you are taking SOMATULINE® AUTOGEL®.

  • are breast-feeding.

Other warnings you should know about:

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to SOMATULINE® AUTOGEL®. Dizziness and headaches can occur after the first dose and when the dose is increased.

You may develop Pancreatic Exocrine Insufficiency (PEI) when taking SOMATULINE® AUTOGEL®. PEI is a condition where your pancreas doesn’t make enough digestive enzymes. These enzymes are responsible for breaking down food for your body to absorb.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with SOMATULINE® AUTOGEL®:

  • Cyclosporine, which is a drug that blocks the activity of the immune system.
  • Bromocriptine, which is a drug that blocks prolactin (a hormone released by the pituitary gland).
  • Bradycardia inducing drugs, which are drugs that slow heart rate (e.g., beta-blockers).
  • Insulin and oral hypoglycemics, which are drugs that lower blood sugar levels.
  • Drugs that are mainly metabolized by the liver enzyme CYP3A4 with a low therapeutic index (e.g., Sirolimus, tacrolimus).

How to take SOMATULINE® AUTOGEL®:

  • Take SOMATULINE® AUTOGEL® exactly as your healthcare professional has told you. Speak to your healthcare professional if you are not sure.
  • SOMATULINE® AUTOGEL® is given as a deep subcutaneous (under the skin) injection into the buttock or the upper outer thigh.
  • SOMATULINE® AUTOGEL® is given by a healthcare professional or a properly trained person.
  • You may give yourself an injection, in the thigh region only. You should be properly trained and be able to follow the Instructions for Use of SOMATULINE® AUTOGEL®

Usual Adult Dose: Treatment for Acromegaly

The recommended starting dose is one injection of SOMATULINE® AUTOGEL® 90 mg every 28 days. If you have liver or kidney problems, the recommended starting dose is one injection of SOMATULINE® AUTOGEL® 60 mg every 28 days. Your healthcare professional:

  • May change the dose or the length of time between your injections. This depends on how your symptoms and hormones respond to the treatment and whether you have liver or kidney problems.
  • Will tell you how long you need to receive SOMATULINE® AUTOGEL®.

Treatment for Enteropancreatic Neuroendocrine Tumours or Carcinoid Syndrome

The recommended dose is one injection of SOMATULINE® AUTOGEL® 120 mg every 28 days. Your healthcare professional may change your dose if you have liver or kidney problems. They will tell you how long you need to receive SOMATULINE® AUTOGEL®. If you are already being treated for enteropancreatic neuroendocrine tumours, you do not need to take an extra dose of SOMATULINE® AUTOGEL® for the treatment of carcinoid syndrome.

Instructions for Use

Attention: Read all the instructions carefully before starting the injection. This specific technique must be followed to give the dose. The following instructions explain how to inject SOMATULINE® AUTOGEL®.

SOMATULINE® AUTOGEL® is supplied in a ready to use pre-filled syringe. It is fitted with an automatic safety system where the needle will be pulled inside after the full dose is given. This is to prevent needle stick injury.

  1. 1. Remove SOMATULINE® AUTOGEL® from the fridge 30 minutes before the injection. Injecting cold medication may be painful. Keep laminated pouch sealed until just prior to injection.
  2. 2.

    Before opening the pouch, check that the pouch is intact and that the medication has not expired.

    Do not use the pre-filled syringe:

    • If you drop or damage it, or
    • If the pre-filled syringe or pouch appears damaged in any way, or
    • If the product has expired. The expiry date is printed on the outer carton and the pouch.

      If any of the above apply, contact your healthcare professional.

  3. 3. Wash your hands with soap and ensure there is a clean area for preparation.
  4. 4. Tear-open the pouch along the dotted line. Take out the pre-filled syringe.
  1. 5. Prior to administration, look closely at the SOMATULINE® AUTOGEL® syringe. Check for particles and discolouration. The content of the prefilled syringe has a gel-like appearance. It will be white to pale yellow in colour. Do not administer if you see particles or if there is a change in colour. The solution can also contain bubbles that can clear up during injection. This is normal.
  2. 6.

    Select an injection site. Avoid areas with moles, scar tissue, reddened skin, or skin that feels bumpy. Be sure to switch between (alternate) the right and left side each time an injection is given. The location of the injection site is based on who is giving the injection. If the injection is given by:

    6a: a healthcare professional (HCP) or someone else like a trained family member or friend: The upper external quadrant of the buttock or upper outer thigh, or

    6b: yourself: The upper outer part of your thigh

    6a 6b

    (Upper external quadrant of buttock) (upper outer thigh)

  1. 7. Clean the injection site with a sterile gauze without rubbing the skin too much.
  2. 8. Before injecting, take the pre-filled syringe out of its tray. Discard the tray.
  1. 9. Remove the needle cap by pulling off and discard it.
  1. 10.

    Use your thumb and index finger (of the hand not holding the syringe) to stretch and flatten the skin. Do not pinch, fold, or press on the skin at the injection site. Use a strong, straight, dart-like motion to quickly insert the needle. Be sure to insert the needle perpendicular (90 degree angle) to and all the way into your skin. It is very important that you insert the needle completely. You should not see any needle once it is inserted all the way into your skin.

    Injection by HCP or a trained person

    Self-injection, injection by HCP or a trained person

  1. 11. Let go of the injection site area that has been flattened by your hand. Using your other hand, push the plunger with steady and very firm pressure. The medication is thicker and harder to push than you might expect. Typically 20 seconds are needed. Inject the full dose and give a final push to make sure you cannot push it any further. Keep your thumb on the plunger to stop the automatic safety system from being activated too soon.
  1. 12. Without releasing the pressure on the plunger, pull the needle from out of your skin.
  1. 13.

    Take your thumb off the plunger, to release pressure on the plunger. The needle will be automatically pulled into the needle guard where it will be locked permanently.

    Self-injection, injection by HCP or a trained person

    Injection by HCP or a trained person

  1. 14. Use a dry cotton ball or sterile gauze and apply gentle pressure to the injection site. This will help to prevent any bleeding. Do NOT rub or massage the injection site after the injection.
  2. 15. Properly dispose of the used syringe.

Overdose:

If you think you, or a person you are caring for, have taken too much SOMATULINE® AUTOGEL®, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

As soon as you realize that you have missed an injection, contact your healthcare professional. They will give you advice about the timing of your next injection. DO NOT give yourself extra injections to make up for the one that you have forgotten.

What are possible side effects from using SOMATULINE® AUTOGEL®?

These are not all the possible side effects you may have when taking SOMATULINE® AUTOGEL®. If you experience any side effects not listed here, tell your healthcare professional.

  • Cold-like symptoms (cough, runny nose, sore throat, fever)
  • Confusion
  • Constipation
  • Dizziness
  • Dry mouth
  • Excessive sweating, night sweats
  • Fatty stools (stools may be bulky and appear pale and oily)
  • Feeling hot with reddening of the skin
  • Flatulence (passing gas)
  • Hair loss
  • Hard swelling of the injection site, and rarely a persistent hard swelling
  • Heartburn
  • Indigestion
  • Joint, bone, or mouth pain
  • Loss of appetite
  • Muscle pains or spasms
  • Nausea
  • Pain during menstruation
  • Ringing in the ears
  • Shaking
  • Swelling in the arms
  • Swollen tummy
  • Weakness, numbness, tingling or pain in the hands, feet, or back
  • Weight loss

SOMATULINE® AUTOGEL® can cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and other tests like gall bladder ultrasound. They will interpret the results.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
VERY COMMON
Abdominal painX
Diarrhea or loose stoolsX
Formation of gallstones in the gall bladder: sudden severe pain in the upper right abdomen which may last for hours, maybe accompanied by nausea and vomitingX
HeadacheX
VomitingX
Anemia (decreased number of red blood cells): fatigue, loss of energy, weakness, shortness of breathX
COMMON
Injection site reaction: site of injection may be tender, warm, swollen, red or itchy with a build-up of pus under the skinX

Decreased heart rate

(bradycardia)

X
Eye problems: clouding of the lens in the eye, blurry vision, eye redness, dim vision, and/or eye painX
Heart Disorders (disorders affecting your heart muscle, valves or rhythm): Chest pain, or chest discomfort, high blood pressure, irregular heart rhythm, shortnessX

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
of breath, fainting, swelling of the legs, ankles and feet, weakness
High blood pressure or worsening of high blood pressure: headaches, nausea and vomitingX
Underactive thyroid gland (hypothyroidism): changes in heart rate, appetite or weight, tiredness, feeling cold or swelling at the front of the neckX
Pancreatitis (inflammation of the pancreas): severe abdominal pain which may spread out towards the back, nausea, vomiting, increased heart rateX
Liver problems: yellowing of the skin or eyes, dark urine, abdominal pain, nausea, vomiting, loss of appetite, itching, bruising, weight lossX
Diabetes, worsening of diabetes, or high blood sugar: unusual thirst, frequent urination, extreme fatigue or lack of energy, tingling or numbness in the hands or feetX
Low blood sugar: dizziness, sweating, confusion, headache, blurred vision, fast heartbeat, mood changesX
Urinary tract infection (infection in urinary system including kidneys, ureters, bladder and urethra): Pain or burning sensation while urinating, frequent urination, blood in urine, pain in the pelvis, strong smelling urine, cloudy urineX
Depression (sad mood that won’t go away): difficulty sleeping or sleeping too much, changes in appetite or weight, feelings of anxiety, worthlessness, guilt, regret, helplessness, hopelessness or reduced libido (sex drive)X
New Tumour growthX
Deafness: loss of hearingX
RARE
Allergic skin reactions: rash, hives, itching, rednessX
UNKNOWN
Severe allergic reactions:X

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
swollen face, lips, mouth or tongue, tightness in chest, shortness of breath or wheezing fainting, dizziness or feeling lightheaded due to a drop in blood pressure, flushing or redness of the skin, rash or hives
Inflammation of the bile duct: pain in the upper right part of your belly (abdomen), fever, chills, yellowing of the skin and eyes (jaundice), nausea, vomiting, clay-coloured stools, dark urine, tirednessX
Pancreatic Exocrine Insufficiency (pancreas doesn’t make enough digestive enzymes): fatty stools (too much fat in your stool), diarrhea, loose stools, abdominal bloating and weight lossX

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Store SOMATULINE® AUTOGEL® at 2ºC-8ºC in a refrigerator in its original package in order to protect from light. Do not freeze.
  • Keep out of the reach and sight of children. Do not use after the expiry date shown on the labels and box. Each syringe is packed individually.
  • Once removed from the fridge, SOMATULINE® AUTOGEL® can be put back in the fridge for storage and later use if:

    • it is left in its sealed pouch, and
    • it has been stored for less than a total of 72 hours at below 40°C, and
    • the storage outside the fridge has not occurred more than 3 times.

If you want more information about SOMATULINE® AUTOGEL®:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website www.ipsen.ca, or by calling 1-855-215-2288.

SOMATULINE® AUTOGEL® is a registered trademark of Ipsen Pharma S.A.S.

Last Revised AUG 08, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02283395

Revision date stated in the text: August 8, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Somatuline Autogel

Rx or OTC
Prescription (Rx)?
DIN 02283395, 02283409, 02283417
Schedule(s) PRESCRIPTION
Active ingredient(s) Lanreotide (lanreotide acetate)
Dosage form(s) Solution (Extended-Release)
Route(s) of administration Subcutaneous
Drug class (WHO ATC)
  1. H Systemic hormonal preparations, excl. sex hormones and insulins
    1. H01 Pituitary and hypothalamic hormones and analogues
      1. H01C Hypothalamic hormones
        1. H01CB Somatostatin and analogues
          1. H01CB03 Lanreotide
Company IPSEN BIOPHARMACEUTICALS CANADA INC
Current status Marketed
Strengths and forms
DIN Strength Dosage form(s) Current status
02283395 60 MG Solution (Extended-Release) Marketed February 16, 2022
02283409 90 MG Solution (Extended-Release) Marketed February 16, 2022
02283417 120 MG Solution (Extended-Release) Marketed December 15, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 12, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.